Helene Duret

2.8k total citations
15 papers, 1.6k citations indexed

About

Helene Duret is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Helene Duret has authored 15 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Helene Duret's work include Immune Cell Function and Interaction (9 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). Helene Duret is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). Helene Duret collaborates with scholars based in Australia, France and United States. Helene Duret's co-authors include Mark J. Smyth, Michele W.L. Teng, Upulie Divisekera, John Stagg, Sherene Loi, Stephen R. Mattarollo, Shin Foong Ngiow, Yuting Ma, Laurence Zitvogel and Hideo Yagita∥ and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Helene Duret

15 papers receiving 1.6k citations

Peers

Helene Duret
Joel Crespo United States
Barbara Castella Italy
Jens Volkmer United States
Andrea G.S. Buggins United Kingdom
Francesca Arruga Italy
Miren Zuazo Spain
Che Xiangming Japan
Justin A. Shyer United States
Mark G. Cadungog United States
Thomas Köhnke Germany
Joel Crespo United States
Helene Duret
Citations per year, relative to Helene Duret Helene Duret (= 1×) peers Joel Crespo

Countries citing papers authored by Helene Duret

Since Specialization
Citations

This map shows the geographic impact of Helene Duret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helene Duret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helene Duret more than expected).

Fields of papers citing papers by Helene Duret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helene Duret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helene Duret. The network helps show where Helene Duret may publish in the future.

Co-authorship network of co-authors of Helene Duret

This figure shows the co-authorship network connecting the top 25 collaborators of Helene Duret. A scholar is included among the top collaborators of Helene Duret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helene Duret. Helene Duret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Paget, Christophe, Helene Duret, Maya Hassane, et al.. (2015). CD3(bright) signals on gamma delta T cells identify IL-17A-producing V gamma 6V delta 1( ) T cells. Immunology and Cell Biology. 93(2). 2 indexed citations
2.
Paget, Christophe, Melvyn T. Chow, Nicholas A. Gherardin, et al.. (2014). CD3bright signals on γδ T cells identify IL‐17A‐producing Vγ6Vδ1+ T cells. Immunology and Cell Biology. 93(2). 198–212. 65 indexed citations
3.
Chow, Melvyn T., Helene Duret, Daniel M. Andrews, et al.. (2014). Type I NKT‐cell‐mediated TNF‐α is a positive regulator of NLRP3 inflammasome priming. European Journal of Immunology. 44(7). 2111–2120. 21 indexed citations
4.
Ma, Yuting, Stephen R. Mattarollo, Sandy Adjemian, et al.. (2013). CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy. Cancer Research. 74(2). 436–445. 117 indexed citations
5.
Chow, Melvyn T., Jaclyn Sceneay, Christophe Paget, et al.. (2012). NLRP3 Suppresses NK Cell–Mediated Responses to Carcinogen-Induced Tumors and Metastases. Cancer Research. 72(22). 5721–5732. 155 indexed citations
6.
Teng, Michele W.L., Matthew D. Vesely, Helene Duret, et al.. (2012). Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State. Cancer Research. 72(16). 3987–3996. 88 indexed citations
7.
Paget, Christophe, Helene Duret, Shin Foong Ngiow, et al.. (2012). Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma. OncoImmunology. 1(8). 1313–1322. 8 indexed citations
8.
Paget, Christophe, Melvyn T. Chow, Helene Duret, Stephen R. Mattarollo, & Mark J. Smyth. (2012). Role of γδ T Cells in α-Galactosylceramide–Mediated Immunity. The Journal of Immunology. 188(8). 3928–3939. 40 indexed citations
9.
Mattarollo, Stephen R., et al.. (2012). Transient Foxp3+ regulatory T‐cell depletion enhances therapeutic anticancer vaccination targeting the immune‐stimulatory properties of NKT cells. Immunology and Cell Biology. 91(1). 105–114. 42 indexed citations
10.
Mattarollo, Stephen R., Alison C. West, Helene Duret, et al.. (2012). NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma. Blood. 120(15). 3019–3029. 61 indexed citations
11.
Mattarollo, Stephen R., Sherene Loi, Helene Duret, et al.. (2011). Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors. Cancer Research. 71(14). 4809–4820. 256 indexed citations
12.
Stagg, John, Upulie Divisekera, Helene Duret, et al.. (2011). CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis. Cancer Research. 71(8). 2892–2900. 320 indexed citations
13.
Teng, Michele W.L., Bianca von Scheidt, Helene Duret, Jennifer E. Towne, & Mark J. Smyth. (2011). Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases. Cancer Research. 71(6). 2077–2086. 44 indexed citations
14.
Stagg, John, Sherene Loi, Upulie Divisekera, et al.. (2011). Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapy. Proceedings of the National Academy of Sciences. 108(17). 7142–7147. 381 indexed citations
15.
Duret, Helene, et al.. (2011). 抗IL-23単クローン抗体は標的療法または IL-2との併用で相乗作用を示し,腫瘍増殖と転移を抑制する. Cancer Research. 71(6). 2077–2086. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joel Crespo Breakdown of academic impact, for papers by Barbara Castella Breakdown of academic impact, for papers by Jens Volkmer Breakdown of academic impact, for papers by Andrea G.S. Buggins Breakdown of academic impact, for papers by Francesca Arruga Breakdown of academic impact, for papers by Miren Zuazo Breakdown of academic impact, for papers by Che Xiangming Breakdown of academic impact, for papers by Justin A. Shyer Breakdown of academic impact, for papers by Mark G. Cadungog Breakdown of academic impact, for papers by Thomas Köhnke
Rankless by CCL
2026